People · Operator
Named in public records as an officer, director or promoter · active 2015–2021 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SkinJect, Inc. | — | Biotechnology | Series A | $8.3M | $19.6M | 2015 |
| InClinica, Inc. | — | Other Health Care | Seed | $5.7M | $9.3M | 2018 |
James Nolan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Nolan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph Donnelly | 2 | 4 |
| Michael Fare | 2 | 2 |
| Edward J. Brennan | 1 | 3 |
| James R Douglass | 1 | 3 |
| James K. Bannon | 1 | 2 |
| Anthony Florence | 1 | 2 |
| John W. Lynch | 1 | 2 |
| James A. Bannon | 1 | 2 |
| Kenneth Melani | 1 | 2 |
| Kenneth Melani, MD | 1 | 1 |
| Dilip R. Limaye | 1 | 1 |
| John R. Hathaway | 1 | 1 |
| Bruce R. Wietlisbach | 1 | 1 |
| Dilip J. Limaye | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.